Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

PHASE3TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

September 28, 2023

Study Completion Date

September 28, 2023

Conditions
Seizures Associated With EMAS
Interventions
DRUG

GWP42003-P

oral solution

DRUG

Placebo

oral solution

Trial Locations (14)

16147

Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS, Genova

27100

IRCCS Fondazione Istituto Neurologico Nazionale D. Mondino Pavia, Pavia

27157

Wake Forest Baptist Health Sciences, Department of Neurology, Winston-Salem

29425

Medical University of South Carolina, Charleston

30329

Healthcare of Atlanta, Atlanta

35233

Children's Hospital of Alabama, Birmingham

37126

UOC Neuropsichiatria Infantile AOUI Verona, Verona

45229

Cincinnati Children's Hospital Medical Center - TS Clinic, Cincinnati

50139

Azienda Ospedaliero Universitaria Ospedale Pediatrico Meyer, Florence

55905

Mayo Clinic, Rochester

60611

Ann & Robert H. Lurie Children's Hospital, Chicago

78723

Dell's Children's Hospital, Austin

95817

University of California Davis Health, Sacramento

98105

Seattle Children's Hospital, Seattle

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY